In this article, there was a significant difference in AFP levels between the cHCC-CC group and the ICC group, with 45.8% of patients with cHCC-CC having abnormally elevated AFP levels and 37.5% having abnormally elevated CA19−9 levels. The gene discussed is AFP; the disease is intrahepatic cholangiocarcinoma.